GlaxoSmithKline and partner Johnson & Johnson have submitted their next-gen IL-6 arthritis med sirukumab to the EMA a month before rivals Regeneron and…

The latest in the long spree of partnerships to pair PD1 and PD-L1 inhibitors with other approaches to boost efficacy has arrived with a deal between Roche’s…

GlaxoSmithKline increased the value of its gene therapy pact with MolMed at a time when it is looking to establish itself at the forefront of the nascent field…

Amgen is working on sorting out its immuno-oncology strategy. It’s taken another step in that direction in a new deal with Boehringer Ingelheim to gain global…

A biotech borne out of a JV between Bayer’s new research deals arm and CRISPR Therapeutics will start operations at life sciences hub Kendall Square in…

Johnson & Johnson ($JNJ) has partnered with a microbiome startup in its JLABS San Diego incubator to develop treatments for inflammatory skin diseases.

A snapshot survey of biotech chiefs during the second quarter has shown that their confidence to be able to raise funds has doubled since Q1, but they are a…

Bristol-Myers Squibb is adding to an existing partnership with Bavarian Nordic to start a Phase II combo trial of Opdivo with Bavarian’s cancer vaccine CV301…